Ligand Pharmaceuticals
LGND
#3601
Rank
โ‚ฌ3.12 B
Marketcap
158,78ย โ‚ฌ
Share price
-1.93%
Change (1 day)
34.65%
Change (1 year)

Revenue for Ligand Pharmaceuticals (LGND)

Revenue in 2025 (TTM): โ‚ฌ0.22 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.21 Billion. In 2024 the company made a revenue of โ‚ฌ0.16 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ligand Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.22 B38.12%
2024 โ‚ฌ0.16 B35.21%
2023 โ‚ฌ0.11 B-26.31%
2022 โ‚ฌ0.16 B-34.13%
2021 โ‚ฌ0.24 B61.46%
2020 โ‚ฌ0.15 B41.15%
2019 โ‚ฌ0.10 B-51.15%
2018 โ‚ฌ0.21 B86.91%
2017 โ‚ฌ0.11 B13.51%
2016 โ‚ฌ0.10 B57.52%
2015 โ‚ฌ65.77 M23.94%
2014 โ‚ฌ53.06 M49.64%
2013 โ‚ฌ35.46 M49.44%
2012 โ‚ฌ23.72 M2.6%
2011 โ‚ฌ23.12 M30.7%
2010 โ‚ฌ17.69 M-34.89%
2009 โ‚ฌ27.18 M39.11%
2008 โ‚ฌ19.53 M121.26%
2007 โ‚ฌ8.83 M-84.42%
2006 โ‚ฌ56.69 M-59.01%
2005 โ‚ฌ0.13 B18.33%
2004 โ‚ฌ0.11 B4.27%
2003 โ‚ฌ0.11 B21.26%
2002 โ‚ฌ92.44 M6.95%
2001 โ‚ฌ86.44 M66.95%
2000 โ‚ฌ51.77 M27.5%
1999 โ‚ฌ40.61 M172.27%
1998 โ‚ฌ14.91 M-65.76%
1997 โ‚ฌ43.56 M39.73%
1996 โ‚ฌ31.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚ฌ30.89 B 14,217.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚ฌ22.09 M-89.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.37 B 16,757.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ55.17 B 25,467.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.92 B 24,891.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ51.03 B 23,551.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.25 B 19,019.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ9.46 B 4,287.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 36,578.70%๐Ÿ‡บ๐Ÿ‡ธ USA